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Aims and Limits of the Cochrane Collaboration
The Cochrane Collaboration (CC) was created in 1993 with the aim of systematically reviewing
published research in order to facilitate the selection of appropriate interventions by health
professionals and policy-makers [1]. CC systematic reviews focus on a wide range of health-
care interventions and typically consider evidence only from randomized controlled trials
(RCTs). Because they rely on chance to minimize the potential for epidemiological confound-
ing, RCTs are commonly acknowledged as the strongest, least biased source of evidence on par-
ticular therapies or medical interventions for clinical practice. Similarly, it is well known that
their utility in evaluating public health interventions is not always optimal [2] and, as a conse-
quence, can result in distorted conclusions [3].
We specifically refer to a series of CC systematic reviews aimed at assessing the benefits of
deworming for soil-transmitted helminthiases (STH) [4–6] in children, which we believe is
affected by a significant methodological bias. Two essential characteristics of this intervention,
and of the infections it targets, were not considered by the reviewers when they chose to restrict
evidence to data derived only from RCTs.
Recovery from STH-Associated Morbidity Is a Long-Term Process
TheWorld Health Organization (WHO) recommends a sustained program of mass deworm-
ing for preschool-age and school-age children in areas endemic for STH, corresponding to 10–
12 years of treatment for each child [7]. The aim of such a programme is to keep STH infec-
tions to as low a level of intensity as possible in order to prevent and eliminate morbidity, thus
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protecting a child during his or her physical and cognitive development [7]. The “intervention”
to evaluate is therefore not represented by one or two rounds of treatment but by the cumula-
tive deworming experience extending throughout childhood. The fact that RCTs have consid-
erably shorter follow-up times means they cannot capture the real effects of the deworming
intervention, and conclusions drawn from this evidence risk being severely biased.
The distribution of worms among human hosts is not uniform; only a minority of individu-
als in a community will have infection at a level sufficiently high to cause morbidity (i.e., at
moderate or high intensities of worm burdens) [8]. Estimates indicate that, where the preva-
lence of infection with Ascaris lumbricoides is 50%, approximately 20% of the children in the
community will have moderate- or high-intensity infections, and therefore exhibit morbidity
[9]. However, deworming tablets are administered to the entire child population living in an
endemic area (because of public health considerations such as the high cost and logistical bur-
den of test-and-treat approaches, the low sensitivity of field-applicable diagnostic techniques,
the relative safety of the medicines, the limited health infrastructure and poor access to treat-
ment, and the low health-seeking behavior, among others). Consequently, the deworming
intervention will directly benefit only a portion of the treated children, and will obviously pro-
vide no benefit to children who are not infected. It is therefore unreasonable to evaluate the
benefits of deworming among all the children who are treated, instead of only among those
who are infected.
Not surprisingly, the CC review concludes that the intervention may improve weight gain
only in children “known to have worm infection” [6]. A systematic review is hardly necessary
to point out that children without worms do not directly benefit from the administration of a
deworming tablet.
In conclusion, the main challenges of using RCTs to evaluate the benefits of deworming
include: (1) the short evaluation time periods relative to the longer time needed to observe
accrued benefits; and (2) the need to assess the outcome of the intervention by pooling together
infected and uninfected children alike, thus diluting the known benefits.
The use of RCTs or quasi-RCTs for the evaluation of deworming interventions has already
received considerable criticism [7,10–15]. However, the most recent CC review on this topic
[6] does not address these criticisms, but rather perseveres in its biased methodological
approach, thus highlighting its considerable limitations. Not only is such a review of little value
in guiding global deworming policy, it could also generate confusion among public health plan-
ners and practitioners in endemic countries, thus contributing to possible withdrawal from
treatment of millions of children suffering from STH.
We are convinced of the need to properly evaluate deworming interventions which, despite
their simplicity, carry significant logistic and cost burdens. The cost-benefits of such interven-
tions need to be compared with other health interventions (such as vaccination, sanitation, and
maternal and child health interventions). A proper evaluation should be organized.
Some Examples of Studies Demonstrating the Importance of
Maintaining a LowWorm Burden
• The amount of blood lost to heavy-intensity hookworm infection has been precisely
measured [16,17]. Severely infected children lose more than double the daily iron
requirement [17]. It is especially difficult for those with limited iron dietary input to
compensate such a daily loss of iron [17,18].
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004165 October 22, 2015 2 / 4
References
1. Hill GB. Archie Cochrane and his legacy. An internal challenge to physicians’ autonomy? J Clin Epide-
miol. 2000; 53(12):1189–92. PMID: 11146263
2. Shelton JD. Evidence-based public health: not only whether it works, but how it can be made to work
practicably at scale. Glob Health Sci Pract. 2014; 3:253–8.
3. Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational chal-
lenges: systematic review of randomized controlled trials. BMJ. 2003; 327:1460–1.
4. Dickson R, Awasthi S, Demellweek C, Williamson P. WITHDRAWN: Anthelmintic drugs for treating
worms in children: effects on growth and cognitive performance (Cochrane Review). Cochrane Data-
base Syst Rev. 2007 Jul 18;(2):CD000371.
5. Taylor-Robinson DC, Maayan N, Soares-Weiser K, Donegan S, Garner P. Deworming drugs for soil-
transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school per-
formance. Cochrane Database Syst Rev. 2012; Cochrane Database Syst Rev. 2012; 11:CD000371.
doi: 10.1002/14651858.CD000371.pub5 PMID: 23152203
6. Taylor-Robinson DC, Maayan N, Soares-Weiser K, Donegan S, Garner P (2015) Deworming drugs for
soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school
performance. Cochrane Database Syst Rev. 2015 Jul 23; 7:CD000371. doi: 10.1002/14651858.
CD000371.pub6 PMID: 26202783
7. Eliminating soil-transmitted helminthiases as a public health problem in children: progress report 2001–
2010 and strategic plan 2011–2020. Geneva: World Health Organization; 2012.
8. Gabrielli AF, Montresor A, Engels D, Savioli L. Preventive Chemotherapy in Human Helminthiasis: The-
oretical and operational aspects. Transactions of the Royal Society of Tropical Medicine and Hygiene
2011: 105: 683–693. doi: 10.1016/j.trstmh.2011.08.013 PMID: 22040463
9. Montresor A, à Porta N, Albonico M, Gabrielli AF, Jankovic D, Fitzpatrick C et al. Soil-transmitted hel-
minthiasis. Relationship between prevalence and classes of intensity of infection. Trans R Soc Trop
Med Hyg. 2015; 109:262–7. doi: 10.1093/trstmh/tru180 PMID: 25404186
10. Bhargava A. Treatment for intestinal helminth infection. Conclusions should have been based on
broader considerations. BMJ. 2000; 321:1225.
11. Bundy D, Peto R. Treatment for intestinal helminth infection. Studies of short term treatment cannot
assess long term benefits of regular treatment. BMJ. 2000; 321:1225. PMID: 11185586
12. Cooper E. Treatment for intestinal helminth infection. Message does not follow from systematic review’s
findings. BMJ. 2000; 321:1225–6.
13. Michael E. Treatment for intestinal helminth infection. Contrary to authors’ comments, meta-analysis
supports global helminth control initiatives. BMJ. 2000; 321:1224–5. PMID: 11073529
• In areas of high endemicity, women given albendazole had a lower rate of severe ane-
mia during pregnancy [19]. Birth weight of infants of women who had received alben-
dazole significantly improved, and infant mortality at 6 months fell dramatically [20].
• Several hospital-based studies have documented and quantified an elevated mortality
due to:
• intestinal obstruction caused by heavy intensity infections with A. lumbricoides [21]
(morbidity 12 million cases; mortality 10,000 cases); and
• dysentery syndrome caused by heavy-intensity infections with Trichuris trichiura
[22,23].
• Evidence from veterinary studies in experimentally infected pigs has demonstrated
damage to the gut surface—flattening or atrophy of villi—and the consequent maldi-
gestion and malabsorption in moderate- and heavy-intensity ascariasis [24].
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004165 October 22, 2015 3 / 4
14. Savioli L, Neira M, Albonico M, Beach MJ, Chwaya HM, Crompton DW et al. Treatment for intestinal
helminth infection. Review needed to take account of all relevant evidence, not only effects on growth
and cognitive performance. BMJ. 2000; 321:1226–7. PMID: 11185587
15. Montresor A, Gabrielli AF, Engels D, Daumerie D, Savioli L. Has the NTD community neglected evi-
dence-based policy? [Expert commentary of the viewpoint by Nagpal S, Sinclair D, Garner P]. PLoS
Negl Trop Dis. 2013; 7:e2299. doi: 10.1371/journal.pntd.0002299 PMID: 23875037
16. Hall A, Hewitt G, Tuffrey V, de Silva N. A review andmeta-analysis of the impact of deworming of intesti-
nal worms on child growth and nutrition. Matern Child Nutr. 2008; 4:118–236. doi: 10.1111/j.1740-8709.
2007.00127.x PMID: 18289159
17. Stoltzfus RJ, Albonico M, Chwaya HM, Savioli L, Tielsch J, Schulze K, Yip R. Hemoquant determination
of hookworm-related blood loss and its role in iron deficiency in African children. Am J Trop Med Hyg.
1996; 55:399–404. PMID: 8916795
18. Jonker FAM, Calis JCJ, Phiri K, Brienen EAT, Khoffi H et al. Real-time PCR Demonstrates Ancylos-
toma duodenale Is a Key Factor in the Etiology of Severe Anemia and Iron Deficiency in Malawian Pre-
school Children. PLoS Negl Trop Dis. 2012; 6(3):e1555. doi: 10.1371/journal.pntd.0001555 PMID:
22514750
19. Christian P, Khatry SK, West KP Jr. Antenatal anthelminthic treatment, birthweight, and infant survival
in rural Nepal. Lancet. 2004; 364(9438):981–3. PMID: 15364190
20. Joseph SA, Casapía M, Blouin B, Maheu-Giroux M, Rahme E, Gyorkos TW. Risk factors associated
with malnutrition in one-year-old children living in the Peruvian Amazon. PLoS Negl Trop Dis. 2014; 8
(12):e3369. doi: 10.1371/journal.pntd.0003369 PMID: 25503381
21. Silva De et al. Morbidity and mortality in intestinal obstruction caused by Ascaris lumbricoides. Trop
Med Int Health. 1997; 2(2):189–90.
22. Stephenson LS, Holland CV, Cooper ES. The public health significance of Trichuris trichiura. Parasitol-
ogy. 2000; 121 Suppl:S73–95. PMID: 11386693
23. Kaminsky RG, Castillo RV, Flores CA. Growth retardation and severe anemia in children with Trichuris
dysenteric syndrome. Asian Pac J Trop Biomed. 2015; 5:581–6.
24. Martin J, Crompton DW, Carrera E, NesheimMC. Mucosal surface lesions in young protein-deficient
pigs infected with Ascaris suum (Nematoda). Parasitology. 1984; 88:333–340. PMID: 6718059
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004165 October 22, 2015 4 / 4
